Key takeaways
Glipizide (Glucotrol XL) and exenatide (Byetta, Bydureon BCise) are both used to treat Type 2 diabetes, but they have several differences beween them. Glipizide is taken by mouth, usually once or twice daily, and it helps lower blood sugar by telling your pancreas to release more insulin. Exenatide, on the other hand, is an injectable medication. It helps manage your blood sugar by mimicking a hormone that tells your body to release insulin and blocks sugar release from your liver. Glipizide is available as a lower-cost generic, while exenatide is only available as a brand-name medication, making it more expensive. Glipizide can cause low blood sugar and weight gain, whereas exenatide is less likely to cause low blood sugar and might even help with weight loss. Exenatide also has a risk of thyroid cancer and pancreatitis, which are not associated with glipizide.
